Diagnostic Imaging sat down with medical physicist and CT expert Cynthia H. McCollough, PhD, to learn more about the history of CT and its expanding potential in medical imaging.
Despite what has already been an illustrious career in health care, now is not the time to sleep on computed tomography (CT). Fifty years in, CT remains a cornerstone of medical imaging, aiding not only in diagnosis of disease or trauma, but also in helping to plan and guide therapeutic interventions as well as monitor their outcomes.
Withstanding the test of time and new technology, CT has also weathered bouts of criticism over the years. Although questions about overuse and radiation dose exposure have at times hindered its role, the risk/benefit ratio conversation nearly always tips towards the benefits of the modality, with its ability to quickly answer questions that might otherwise lead providers and patients down a road filled with a multitude of less specific—and so-called less ‘risky’—tests.
To help address some of these questions and improve education around dose, the American Association of Physicists in Medicine (AAPM) in 2010 formed the Alliance for Quality Computed Tomography, which provides several educational and informational resources, including a CT Dose-Check, up-to-date CT imaging protocols for both adult and pediatric patients, as well as CT dose and automatic exposure control educational materials.
To learn more about the history of CT and how to optimize its current use, Diagnostic Imaging spoke with Cynthia H. McCollough, PhD, Brooks-Hollern Professor and professor of medical physics and biomedical engineering at Mayo Clinic. McCollough, who is also director, CT Clinical Innovation Center and X-ray Imaging Core, discussed how CT is currently utilized and highlighted the many ways we can optimize its use in different clinical scenarios, especially when taking into account the technology that allows us to personalize the experience for each patient.
In further commemoration of the anniversary, McCollough helped to put together an online gallery through the AAPM that illustrates the amazing history of CT. View the gallery here.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.